In mental health and emergency medicine, the speed of drug delivery can be a critical factor in patient outcomes. Oral thin films are uniquely suited for these applications because they can be administered quickly without the need for a glass of water, making them ideal for patients experiencing acute anxiety, panic attacks, or opioid withdrawal. In emergency settings, the rapid absorption through the sublingual or buccal mucosa allows medication to enter the bloodstream almost as quickly as an injection, providing rapid relief for symptoms like nausea, pain, or allergic reactions.

Insights from the Oral Thin Film Drugs Market suggest that the central nervous system (CNS) segment is one of the most lucrative areas for OTF development. Films for treating schizophrenia and bipolar disorder are particularly effective for "non-compliant" patients, as the film dissolves too quickly to be surreptitiously discarded. Additionally, the development of OTF versions of "rescue" medications is providing patients and first responders with a portable, discreet, and fast-acting tool for managing acute episodes. This versatility is expanding the role of thin films in modern emergency protocols and psychiatric care plans.